Abstrakt:
Aim: To systematically review the evidence on productivity losses due to health problems arising from the COVID-19 pandemic based on evidence from population-level studies.
Methods: Following PRISMA statement, we conducted a systematic review using Medline, Embase, Scopus, Web of Science, EconLit, WHO COVID-19 Research and EuropePMC databases and a grey literature search. We included population-level studies using secondary data and qualitatively assessed eligible studies. For a quantitative cross-study comparison, we calculated losses in 2020 international dollars and as a share of gross domestic product. PROSPERO registration number: CRD42023478059.
Results: 38 studies were eligible for review and 33 studies met the qualitative threshold for inclusion in a quantitative comparison. Most of the studies reported losses in high-income countries and the European region. COVID-19 was a focus of 33 studies while 3 studies investigated losses from both long COVID and excess mortality. The Human Capital Approach dominated (30 studies) and no study used the Friction Cost Method. Most of the studies (84%) reported on premature mortality losses and a quarter provided estimates of absenteeism losses. We found that the productivity losses ranged from 0% to >10% of gross domestic product; the greatest losses were in the high-income countries and for those aged 40-59 years; and losses among men contributed to around 3/4 of the total burden.
Conclusion: The available evidence on the topic is limited, particularly considering the methodological approaches used. Thus, more research is needed to reach a more comprehensive picture of economy-level productivity losses resulting from the recent pandemic.
Opis:
This preprint has not undergone peer review (when applicable) or any post-submission improvements or corrections. The Version of Record of this article is published in Applied Health Economics and Health Policy, and is available online at https://doi.org/10.1007/s40258-024-00935-8.